These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6782608)

  • 1. Discriminative response control by naloxone in morphine pretreated rats.
    Miksic S; Sherman G; Lal H
    Psychopharmacology (Berl); 1981; 72(2):179-84. PubMed ID: 6782608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discriminative stimulus properties of cyclazocine: generalization studies involving nalorphine, morphine and LSD.
    Rosecrans JA; Chance WT; Spencer RM
    Res Commun Chem Pathol Pharmacol; 1978 May; 20(2):221-37. PubMed ID: 674812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of morphine, naloxone, d,l-cyclazocine, and d-amphetamine on behaviour controlled by a schedule of interresponse time reinforcement.
    Adam-Carrière D; Merali Z; Stretch R
    Can J Physiol Pharmacol; 1978 Oct; 56(5):707-20. PubMed ID: 709412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of evidence for a role of endorphinergic mechanisms in mediating a discriminative stimulus produced by diazepam in rats.
    Shearman GT; Millan MJ; Herz A
    Psychopharmacology (Berl); 1982; 78(3):282-4. PubMed ID: 6296904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative effects of cyclazocine in the squirrel monkey.
    Schaefer GJ; Holtzman SG
    J Pharmacol Exp Ther; 1978 May; 205(2):291-301. PubMed ID: 417173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalization study with some narcotic and nonnarcotic drugs in rats trained for morphine-saline discrimination.
    Miksic S; Shearman G; Lal H
    Psychopharmacology (Berl); 1978 Dec; 60(1):103-4. PubMed ID: 104339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of narcotic agonists and antagonists on schedule-induced water and morphine ingestion.
    Leander JD; McMillan DE; Harris LS
    J Pharmacol Exp Ther; 1975 Nov; 195(2):271-8. PubMed ID: 1237618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effects of opioid agonists and antagonists under a fixed-consecutive-number schedule in rats.
    Picker M; Heise JW; Dykstra LA
    Pharmacol Biochem Behav; 1987 May; 27(1):73-80. PubMed ID: 3615550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent generalization of morphine stimulus properties to meperidine: antagonism by naloxone.
    Bartoletti M; Gaiardi M; Gubellini C; Bacchi A; Babbini M
    Pharmacol Biochem Behav; 1989 Oct; 34(2):429-31. PubMed ID: 2622998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ethylketazocine and morphine alone and in combination with naloxone on schedule-controlled behavior in pigeons.
    Katz JL
    Psychopharmacology (Berl); 1987; 92(4):508-12. PubMed ID: 2888154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulus properties of the narcotic antagonist pentazocine: similarity to morphine and antagonism by naloxone.
    Kuhn DM; Greenberg I; Appel JB
    J Pharmacol Exp Ther; 1976 Jan; 196(1):121-7. PubMed ID: 1246006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus properties of fentanyl and morphine: tolerance and dependence.
    Colpaert FC; Kuyps JJ; Niemegeers CJ; Janssen PA
    Pharmacol Biochem Behav; 1976 Oct; 5(4):401-8. PubMed ID: 12518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation of the negative-reinforcing properties of naloxone and cyclazocine in squirrel monkeys.
    Stretch R; Pink C; Gervaize P
    Can J Physiol Pharmacol; 1980 Apr; 58(4):384-91. PubMed ID: 6770985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.
    Picker MJ; Craft RM; Negus SS; Powell KR; Mattox SR; Jones SR; Hargrove BK; Dykstra LA
    J Pharmacol Exp Ther; 1992 Nov; 263(2):668-81. PubMed ID: 1331411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization.
    Colpaert FC; Janssen PA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):193-9. PubMed ID: 6747824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine effects upon discriminated approach and discriminated avoidance in rats: antagonism by naloxone.
    Babbini M; Gaiardi M; Bartoletti M
    Psychopharmacology (Berl); 1980; 70(1):73-7. PubMed ID: 6775339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bias of morphine generalization to cyclazocine by drug history.
    Paule MG; Wenger GR
    Pharmacol Biochem Behav; 1986 Mar; 24(3):479-83. PubMed ID: 3703883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of naloxone antagonism of the discriminative stimulus properties of morphine in the pigeon.
    Wessinger WD; McMillan DE
    Pharmacol Biochem Behav; 1986 Jul; 25(1):209-14. PubMed ID: 3749228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.